Roivant Sciences (ROIV) Operating Leases (2021 - 2026)
Roivant Sciences (ROIV) posted Operating Leases of $107.4 million for Q1 2026, up 9.07% on a QoQ basis from $98.5 million in Q4 2025, and up 18.94% year-over-year from $90.3 million in Q1 2025.
Roivant Sciences (ROIV) Operating Leases (2021 - 2026) Analysis & Trends
Roivant Sciences' Operating Leases history runs 6 years deep, the most recent figure standing at $107.4 million for Q1 2026.
- Quarterly Operating Leases rose 18.94% year-over-year to $107.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.4 million (up 18.94% YoY) and the FY2026 annual result came in at $107.4 million, up 18.94% from the prior year.
- Operating Leases was $107.4 million for Q1 2026 at Roivant Sciences, up from $98.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $107.4 million in Q1 2026 and bottomed at $45.0 million in Q1 2024.
- A 5-year average of $67.0 million and a median of $54.9 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases dropped 17.06% — and 2025, when it jumped 100.64%.
- Roivant Sciences' Operating Leases stood at $54.9 million in 2022, then retreated by 14.32% to $47.1 million in 2023, then jumped by 92.27% to $90.5 million in 2024, then rose by 8.87% to $98.5 million in 2025, then climbed by 9.07% to $107.4 million in 2026.
- Business Quant data shows ROIV's Operating Leases at $107.4 million in Q1 2026, $98.5 million in Q4 2025, and $89.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.44 Mn |
| Dec 31, 2025 | 98.50 Mn |
| Sep 30, 2025 | 89.84 Mn |
| Jun 30, 2025 | 90.29 Mn |
| Mar 31, 2025 | 90.33 Mn |
| Dec 31, 2024 | 90.48 Mn |
| Sep 30, 2024 | 49.10 Mn |
| Jun 30, 2024 | 45.85 Mn |
| Mar 31, 2024 | 45.02 Mn |
| Dec 31, 2023 | 47.06 Mn |
| Sep 30, 2023 | 48.63 Mn |
| Jun 30, 2023 | 51.81 Mn |
| Mar 31, 2023 | 53.48 Mn |
| Dec 31, 2022 | 54.93 Mn |
| Sep 30, 2022 | 54.09 Mn |
| Jun 30, 2022 | 60.40 Mn |
| Mar 31, 2022 | 62.47 Mn |
| Dec 31, 2021 | 62.09 Mn |
| Sep 30, 2021 | 65.22 Mn |
| Jun 30, 2021 | 65.26 Mn |